Cancer Medicine,
Journal Year:
2024,
Volume and Issue:
13(11)
Published: June 1, 2024
Lung
cancer
remains
the
foremost
reason
of
cancer-related
mortality,
with
invasion
and
metastasis
profoundly
influencing
patient
prognosis.
N-acetyltransferase
10
(NAT10)
catalyzes
exclusive
N
(4)-acetylcytidine
(ac4C)
modification
in
eukaryotic
RNA.
NAT10
dysregulation
is
linked
to
various
diseases,
yet
its
role
non-small
cell
lung
(NSCLC)
unclear.
Our
study
delves
into
clinical
significance
functional
aspects
NSCLC.
Trends in Molecular Medicine,
Journal Year:
2023,
Volume and Issue:
29(9), P. 753 - 764
Published: June 24, 2023
Ferroptosis
suppressor
protein
1
(FSP1)
is
one
of
the
main
regulatory
molecules
ferroptosis.
FSP1
functions
through
FSP1-coenzyme
Q10
(CoQ10)-NAD(P)H
axis
and
vitamin
K
redox
cycle.
regulated
by
upstream
factors,
including
transcription
factors
noncoding
RNA
(ncRNA),
subject
to
epigenetic
modifications,
which
affect
progress
FSP1-related
diseases.
closely
associated
with
poor
prognosis
malignant
tumors
plays
an
important
role
in
disease
treatment.
This
review
aims
provide
a
comprehensive
understanding
ferroptosis
regulation
summarizing
pathways,
possible
mechanisms
involving
FSP1,
relationship
between
Molecular Biomedicine,
Journal Year:
2023,
Volume and Issue:
4(1)
Published: Aug. 24, 2023
Abstract
RNA
modifications
are
dynamic
and
reversible
chemical
on
substrate
that
regulated
by
specific
modifying
enzymes.
They
play
important
roles
in
the
regulation
of
many
biological
processes
various
diseases,
such
as
development
cancer
other
diseases.
With
help
advanced
sequencing
technologies,
role
has
caught
increasing
attention
human
diseases
scientific
research.
In
this
review,
we
briefly
summarized
basic
mechanisms
several
common
modifications,
including
m6A,
m5C,
m1A,
m7G,
Ψ,
A-to-I
editing
ac4C.
Importantly,
discussed
their
potential
functions
cancer,
neurological
disorders,
cardiovascular
metabolic
genetic
developmental
well
immune
disorders.
Through
“writing-erasing-reading”
mechanisms,
regulate
stability,
translation,
localization
pivotal
disease-related
mRNAs
to
manipulate
disease
development.
Moreover,
also
highlighted
review
all
currently
available
RNA-modifier-targeting
small
molecular
inhibitors
or
activators,
most
which
designed
against
m6A-related
enzymes,
METTL3,
FTO
ALKBH5.
This
provides
clues
for
clinical
therapy
future
study
directions
modification
field.
More
in-depth
studies
further
activators
needed
a
thorough
understanding
epitranscriptomics
diagnosis,
treatment,
prognosis
Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
194, P. 106822 - 106822
Published: June 17, 2023
Pancreatic
cancer
(PC)
is
a
serious
gastrointestinal
tract
disease
for
which
the
5-year
survival
rate
less
than
10%,
even
in
developed
countries
such
as
USA.
The
genomic
profile
alterations
and
dysregulated
biological
mechanisms
commonly
occur
PC.
Macroautophagy/autophagy
cell
death
process
that
maintained
at
basal
level
physiological
conditions,
whereas
its
often
changes
during
tumorigenesis.
function
of
autophagy
human
cancers
dual
can
be
oncogenic
onco-suppressor.
Autophagy
potent
controller
tumorigenesis
supportive
PC
escalates
growth
cells
suppression
mediate
death.
also
determines
metastasis
cells,
it
control
EMT
affecting
migration.
Moreover,
starvation
hypoxia
stimulate
glycolysis,
glycolysis
induction
mediated
by
enhancing
Furthermore,
protective
stimulates
drug
resistance
gemcitabine
inhibition
enhance
radiosensitivity.
degrade
MHC-I
to
immune
evasion
regulates
polarization
macrophages
tumor
microenvironment.
Modulation
activity
provided
silibinin,
ursolic
acid,
chrysin
huaier
treatment
Non-coding
RNAs
are
controllers
improve
therapy
response
patients.
mitophagy
shows
dysregulation
PC,
proliferation
cells.
Therefore,
bioinformatics
analysis
demonstrates
autophagy-related
proteins
genes
biomarkers.
Molecular Therapy — Nucleic Acids,
Journal Year:
2023,
Volume and Issue:
32, P. 359 - 368
Published: April 4, 2023
In
the
early
stage,
N4-acetylcytidine
(ac4C)
was
regarded
as
a
conservative
nucleoside
present
on
tRNA
and
rRNA.
Recently,
studies
have
shown
that
ac4C
also
exists
in
human
yeast
mRNA.
N-Acetyltransferase-like
protein
10
(NAT10)
is
first
enzyme
to
be
found
catalyze
production
eukaryotic
RNA
has
acetyltransferase
activity
RNA-binding
activity.
Here,
we
describe
structure
cellular
localization
of
NAT10.
Then,
conclude
active
roles
NAT10
"writer"
mRNA
stability
translation
efficiency,
oocyte
maturation,
bone
remodeling,
fatty
acid
metabolism.
With
respect
disease,
focused
promoting
functions
proliferation,
metastasis,
apoptosis
multiple
tumors.
The
immune
regulatory
role
systemic
lupus
erythematosus
maintenance
virus
replication
influenza
A
are
introduced.
This
review
identifies
potential
target
for
diagnosis,
therapy,
prognosis
clinical
application.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(23)
Published: June 16, 2023
Anti-angiogenic
therapy
has
long
been
considered
a
promising
strategy
for
solid
cancers.
Intrinsic
resistance
to
hypoxia
is
major
cause
the
failure
of
anti-angiogenic
therapy,
but
underlying
mechanism
remains
unclear.
Here,
it
revealed
that
N4-acetylcytidine
(ac4C),
newly
identified
mRNA
modification,
enhances
tolerance
in
gastric
cancer
(GC)
cells
by
promoting
glycolysis
addiction.
Specifically,
acetyltransferase
NAT10
transcription
regulated
HIF-1α,
key
factor
cellular
response
hypoxia.
Further,
acRIP-sequencing,
Ribosome
profiling
sequencing,
RNA-sequencing,
and
functional
studies
confirm
turn
activates
HIF-1
pathway
subsequent
glucose
metabolism
reprogramming
mediating
SEPT9
ac4C
modification.
The
formation
NAT10/SEPT9/HIF-1α
positive
feedback
loop
leads
excessive
activation
induces
Combined
anti-angiogenesis
inhibition
attenuate
inhibit
tumor
progression
vivo.
This
study
highlights
critical
roles
regulation
addiction
proposes
overcome
combining
apatinib
with
inhibition.
Circulation Research,
Journal Year:
2023,
Volume and Issue:
133(12), P. 989 - 1002
Published: Nov. 13, 2023
BACKGROUND:
Heart
failure,
characterized
by
cardiac
remodeling,
is
associated
with
abnormal
epigenetic
processes
and
aberrant
gene
expression.
Here,
we
aimed
to
elucidate
the
effects
mechanisms
of
NAT10
(N-acetyltransferase
10)-mediated
N4-acetylcytidine
(ac4C)
acetylation
during
remodeling.
METHODS:
ac4C
expression
were
detected
in
both
human
mouse
subjects
remodeling
through
multiple
assays.
Subsequently,
acetylated
RNA
immunoprecipitation
sequencing,
thiol-linked
alkylation
for
metabolic
sequencing
(SLAM-seq),
ribosome
(Ribo-seq)
employed
role
ac4C-modified
posttranscriptional
regulation
Additionally,
functional
experiments
involving
overexpression
or
knockdown
conducted
mice
models
challenged
Ang
II
(angiotensin
II)
transverse
aortic
constriction.
RESULTS:
levels
increased
vitro
vivo
models,
as
well
patients
hypertrophy.
Silencing
inhibiting
attenuated
II-induced
cardiomyocyte
hypertrophy
cardiofibroblast
activation.
Next-generation
revealed
changes
humans
global
mRNA
abundance,
stability,
translation
efficiency.
Mechanistically,
could
enhance
stability
efficiency
CD47
ROCK2
transcripts
upregulating
their
modification,
thereby
resulting
an
increase
protein
Furthermore,
administration
Remodelin,
a
inhibitor,
has
been
shown
prevent
impairments
subjected
constriction
suppressing
fibrosis,
hypertrophy,
inflammatory
responses,
while
also
regulating
(Rho
coiled-coil
containing
kinase
2).
CONCLUSIONS:
Therefore,
our
data
suggest
that
modulating
epitranscriptomic
processes,
such
NAT10,
may
be
promising
therapeutic
target
against
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Oct. 27, 2023
Abstract
Cardiovascular
disease
(CVD)
is
the
leading
cause
of
death
in
world,
with
a
high
incidence
and
youth-oriented
tendency.
RNA
modification
ubiquitous
indispensable
cell,
maintaining
cell
homeostasis
function
by
dynamically
regulating
gene
expression.
Accumulating
evidence
has
revealed
role
aberrant
expression
CVD
caused
dysregulated
modification.
In
this
review,
we
focus
on
nine
common
modifications:
N
6
-methyladenosine
(m
A),
1
5-methylcytosine
5
C),
7
-methylguanosine
G),
4
-acetylcytosine
(ac
pseudouridine
(Ψ),
uridylation,
adenosine-to-inosine
(A-to-I)
editing,
modifications
U34
tRNA
wobble.
We
summarize
key
regulators
their
effects
expression,
such
as
splicing,
maturation,
transport,
stability,
translation.
Then,
based
classification
CVD,
mechanisms
which
occurs
progresses
through
are
discussed.
Potential
therapeutic
strategies,
therapy,
reviewed
these
mechanisms.
Herein,
some
(such
stroke
peripheral
vascular
disease)
not
included
due
to
limited
availability
literature.
Finally,
prospective
applications
challenges
discussed
for
purpose
facilitating
clinical
Moreover,
look
forward
more
studies
exploring
roles
future,
there
substantial
uncultivated
areas
be
explored.
Experimental Hematology and Oncology,
Journal Year:
2023,
Volume and Issue:
12(1)
Published: Aug. 3, 2023
Organoids
are
established
through
in
vitro
3D
culture,
and
they
can
mimic
the
structure
physiological
functions
of
organs
or
tissues
vivo.
have
attracted
much
attention
recent
years.
They
provide
a
reliable
technology
platform
for
cancer
research
treatment
valuable
preclinical
model
academic
personalized
medicine.
A
number
studies
confirmed
that
organoids
great
application
prospects
new
drug
development,
screening,
tumour
mechanism
research,
precision
In
this
review,
we
mainly
focus
on
advances
research.
We
also
discussed
opportunities
challenges
facing
organoids,
hoping
to
indicate
directions
development
future.